Eaton (ETN) Posts Record Q3 Earnings, Forecasts Further Growth in 2025
Eaton exceeded expectations in Q3 2025 with record EPS of $3.07 and strong revenue growth to $7 billion.
BTC$60,022.00-4.02%
ETH$1,611.40-2.93%
USDT$0.9986-0.03%
USDC$0.9996-0.01%
XRP$1.06-3.72%
SOL$67.04-2.81%
TRX$0.3262-1.18%
FIGR_HELOC$1.03-0.13%
HYPE$59.29-5.23%
DOGE$0.0751-4.89%
USDS$0.9994-0.02%
RAIN$0.0159+1.07%
LEO$9.45-0.91%
ZEC$401.75-3.79%
XLM$0.1844-4.52%
BTC$60,022.00-4.02%
ETH$1,611.40-2.93%
USDT$0.9986-0.03%
USDC$0.9996-0.01%
XRP$1.06-3.72%
SOL$67.04-2.81%
TRX$0.3262-1.18%
FIGR_HELOC$1.03-0.13%
HYPE$59.29-5.23%
DOGE$0.0751-4.89%
USDS$0.9994-0.02%
RAIN$0.0159+1.07%
LEO$9.45-0.91%
ZEC$401.75-3.79%
XLM$0.1844-4.52%
Pfizer reported Q3 2025 revenue of $16.7 billion and adjusted EPS of $0.87, beating expectations and prompting a full-year EPS guidance raise.
Eaton exceeded expectations in Q3 2025 with record EPS of $3.07 and strong revenue growth to $7 billion.
PSEG reported Q3 2025 earnings of $1.24 per share, beating estimates and raising its full-year outlook amid strong regulated performance.
Freshpet beat Q3 2025 estimates with revenue of $288.8 million, up 14% year-over-year, and raised its outlook to reflect steady cash flow and disciplined spending.
Newell Brands stock plunged over 30% after missing Q3 sales estimates and cutting its full-year outlook due to rising tariff costs.
Chevron reported Q3 2025 earnings of $1.82 per share, topping estimates, though revenue of $48.17 billion missed expectations.
Aon reported Q3 2025 revenue of $4.0 billion and EPS of $3.05, both above expectations, driven by 7% organic growth and strong client demand.
ExxonMobil posted Q3 2025 earnings of $7.5 billion, or $1.76 per share, slightly below expectations but supported by $14.8 billion in cash flow and record production.
Roblox shares slid after the company warned of higher losses for Q4 and 2025, overshadowing robust bookings growth.
Comcast’s Q3 2025 revenue of $31.2 billion and EPS of $1.12 topped estimates, driven by gains in connectivity and theme parks.
Eli Lilly’s Q3 2025 revenue jumped 54% to $17.6 billion with adjusted EPS of $7.02, prompting the company to lift its full-year guidance.
Merck reported Q3 2025 revenue of $17.3 billion and adjusted EPS of $2.58, both above expectations, and raised its full-year outlook.
Fiserv shares plunged after the company reported weak Q3 results, missing earnings expectations and slashing its full-year outlook amid slowing growth and major leadership changes.